Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus
Daniel González(University of North Carolina at Chapel Hill), Edmund V. Capparelli(University of California San Diego), Michael Cohen‐Wolkowiez(Duke University), James M. Chamberlain(George Washington University Hospital), Jian Zhao(Emmes (United States)), Jeffrey T. Guptill(Duke University), Barrie Harper(Clinical Research Institute)
Cited by 9
Related Papers
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
|Clinical Therapeutics|2016|170
Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents
|Clinical Microbiology Reviews|2013|147